Randomized, multicentre, open clinical trial assessing the effectiveness and safety of simplification to atazanavir + ritonavir versus continuation of a stable antiretroviral regimen on lopinavir/ritonavir

Trial Profile

Randomized, multicentre, open clinical trial assessing the effectiveness and safety of simplification to atazanavir + ritonavir versus continuation of a stable antiretroviral regimen on lopinavir/ritonavir

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Aug 2009

At a glance

  • Drugs Atazanavir; Lopinavir/ritonavir; Ritonavir
  • Indications HIV infections; HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms ATAZIP
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 09 Nov 2008 Status changed to completed according to results presented at the 9th International Congress on Drug Therapy in HIV Infection.
    • 09 Nov 2008 Results were presented at the 9th International Congress on Drug Therapy in HIV Infection.
    • 07 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top